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Abstract
Somatic cell fusion is an essential component of skeletal muscle development
and growth and repair from injury. Additional cell types such as trophoblasts
and osteoclasts also require somatic cell fusion events to perform their physio-
logical functions. Currently we have rudimentary knowledge on molecular
mechanisms regulating somatic cell fusion events in mammals. We therefore
investigated during in vitro murine myogenesis a mammalian homolog, Kirrel,
of the Drosophila Melanogaster genes Roughest (Rst) and Kin of Irre (Kirre)
which regulate somatic muscle cell fusion during embryonic development.
Our results demonstrate the presence of a novel murine Kirrel isoform con-
taining a truncated cytoplasmic domain which we term Kirrel B. Protein
expression levels of Kirrel B are inverse to the occurrence of cell fusion events
during in vitro myogenesis which is in stark contrast to the expression profile
of Rst and Kirre during myogenesis in Drosophila. Furthermore, chemical
inhibition of cell fusion confirmed the inverse expression pattern of Kirrel B
protein levels in relation to cell fusion events. The discovery of a novel Kirrel
B protein isoform during myogenesis highlights the need for more thorough
investigation of the similarities and potential differences between fly and
mammals with regards to the muscle cell fusion process.
Introduction
Generation of the syncytial trophoblast during embryonic
development, formation of syncytial skeletal muscle fibers,
and development of osteoclasts highlight important devel-
opmental processes in mammals which are underpinned by
somatic cell fusion events. The occurrence of somatic cell
fusion has been reported in additional tissues including
heart (Dedja et al. 2006), liver (Faggioli et al. 2008;
Fujimiya et al. 2007), brain (Alvarez-Dolado et al. 2003;
Johansson et al. 2008), prostate (Placencio et al. 2010), and
the intestinal epithelium (Davies et al. 2009; Rizvi et al.
2006). Furthermore, it has been hypothesized that somatic
cell fusion could be a mechanism enabling cancer metasta-
sis and in generating resistance to chemotherapy treatments
(Duelli and Lazebnik 2003; Pawelek and Chakraborty
2008). The diverse array of cell types affected by somatic
cell fusion events demonstrates the need for intense study
of this rudimentary understood process. In specific tissue
types, such as skeletal muscle, thousands of cell fusion
events can take place during the development of a single
human muscle fiber in vivo (Peckham 2008); however,
these fusion events are asynchronous and hence suggest
that the somatic cell fusion process is under temporal con-
trol of specific genes.
Significant advances have been made in improving our
understanding of how the somatic cell fusion process is reg-
ulated during embryonic development of the body wall
musculature in the invertebrate model system, Drosophila
melanogaster (Abmayr and Pavlath 2012). Research
findings from Drosophila are increasingly utilized in diverse
research disciplines to strengthen and develop hypotheses
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regarding the molecular underpinnings of development
and diseases in humans (Botas 2007). Indeed, evidence is
emerging which supports the concept of conservation of
key signaling networks between Drosophila and mammals
in regulating the somatic cell fusion process. The dedicator
of cytokinesis (Dock) protein family member Dock1, which
is an atypical guanine nucleotide exchange factor (GEF) for
Rac1 has been demonstrated to be an important regulator
of the in vivo muscle cell fusion process in Drosophila
(Erickson et al. 1997) and mouse models (Laurin et al.
2008). In addition, an mRNA transcript for the Type-1
transmembrane protein Nephrin which is a member of the
immunoglobulin superfamily has recently been reported to
be present in human primary skeletal muscle cell cultures
and in mouse skeletal muscle during the healing response
to cardiotoxin-induced injury (Sohn et al. 2009). Nephrin
is the mammalian homolog to the Drosophila gene sticks
and stones (SnS) (Bour et al. 2000). Loss of SnS results in
inhibition of the muscle cell fusion process during embry-
onic development in Drosophila (Bour et al. 2000), and
intriguingly, loss of Nephrin in zebrafish and in mouse
muscle cells in vitro results in decreased somatic cell fusion
events (Sohn et al. 2009). During the occurrence of muscle
cell fusion events in Drosophila SnS colocalizes in trans at
the cell membrane of fusing muscle cells with an additional
Type-1 transmembrane protein and member of the immu-
noglobulin superfamily, Kin of Irre (Kirre) (Galletta et al.
2004; Sens et al. 2010). Present within the Drosophila gen-
ome is a Kirre paralog termed Roughest (Rst) (Str€unkeln-
berg et al. 2001). Elimination of both Kirre and Rst results
in complete inhibition of the muscle cell fusion process
(Str€unkelnberg et al. 2001). The mammalian homologs to
Rst and Kirre are the Kirrel gene family, Kirrel, Kirrel2, and
Kirrel3 (Neumann-Haefelin et al. 2010). Currently we have
rudimentary knowledge regarding the murine Kirrel family
in skeletal muscle as the vast majority of research on this
gene family has focused on its role in the slit diaphragm of
the mammalian kidney (Donoviel et al. 2001; Gerke et al.
2003; Liu et al. 2003) or in brain development (Gerke et al.
2006; Nishida et al. 2011; Tamura et al. 2005). The Caenor-
habditis. elegans homolog of the Kirrel family is synapto-
genesis abnormal 1 (SYG-1) and it has been implicated in
neural synapse formation (Shen and Bargmann 2003). We
therefore wished to initially examine one of the Kirrel fam-
ily members, Kirrel, during in vitro myogenesis to assess if
evidence could be found which would support a possible
role for Kirrel in regulating the somatic cell fusion process
in murine skeletal muscle. Our results identify a previously
unreported splice variant of Kirrel which is present in mur-
ine muscle cells during in vitro myogenesis and also in the
mouse brain. Alternative splicing is predicted to lead to the
production of a truncated protein compared to the previ-
ously reported Kirrel (Liu et al. 2003) which would result
in significant alternations in the cytoplasmic domain of
Kirrel. We termed this truncated Kirrel transcript Kirrel B.
We also present evidence that expression levels of the Kirrel
B protein isoform are surprisingly inverse to occurrence of
somatic cell fusion events during in vitro myogenesis which
is in stark contrast to the expression profile of Kirre and
Rst during myogenesis in Drosophila, whereby their expres-
sion is highest when the greatest number of cell fusion
events are occurring (Ruiz-Gomez et al. 2000; Str€unkeln-
berg et al. 2001). Furthermore, to substantiate the inverse
link between Kirrel B expression levels and somatic cell
fusion events, we chemically inhibited the cell fusion pro-
cess which resulted in significant upregulation of the Kirrel
B protein isoform. Our results are particularly noteworthy
in light of work on Kirrel homologs Rst and Kirre in Dro-
sophila myogenesis (reviewed in Abmayr and Pavlath 2012
and additionally on the C. elegans homolog of Kirrel, SYG-
1 in synaptogenesis [Shen and Bargmann 2003]). Further
work is required to ascertain how Kirrel B may be involved
in regulating diverse physiological processes such as muscle
cell fusion and neurogenesis.
Material and Methods
Materials
C2C12 cells were obtained from ATCC. All plastic ware
unless otherwise stated were obtained from Fischer scientific.
Dulbecco’s modified eagles medium (DMEM) was obtained
from Lonza (Slough, U.K.). Heat-inactivated (HI) new born
calf serum (NCS) and HI fetal bovine serum (FBS) were
obtained from Gibco (Paisley, U.K.). HI horse serum (HS)
was from Southern Group Laboratory (Corby, U.K.). L-glu-
tamine was obtained from BDH (Poole, U.K.), and penicil-
lin streptomycin solution and trypsin were obtained from
Bio Whittaker (Wokingham, U.K.). Gelatin Type A from
porcine skin primers for two-step reverse transcription poly-
merase chain reaction (RT-PCR) and all chemicals unless
otherwise state were obtained from Sigma Aldrich. Phos-
phate-buffered saline was from Oxoid Ltd., (Basingstoke,
U.K.). Bisperoxo(5-hydroxypyridine-2-carboxyl) oxovanadate
(BpV) was obtained from Calbiochem (Darmstadt,
Germany). Trizol, TaqMan RNA-to-CTTM one-step kit, Taq
man probes, DNA-freeTM Dnase, nuclease-free water, and TE
buffer pH 8.0 were all obtained from Life Technologies
(Paisley, U.K.). PCR plates for qPCR were obtained from
Bio-rad (Hercules, CA). UV plates for creatine kinase (CK)
assay were obtained from BD Biosciences (Oxford, U.K.).
Cell culture
C2C12 murine skeletal myoblast from ATCC (Blau et al.
1985) was initially grown in T75 flasks in a humidified 5%
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CO2 atmosphere at 37°C in growth medium (GM),
composed of: DMEM plus 10% hi FBS, 10% hi NCS, 1%
L-glutamine which was sterile filtered (2 mmol/L final), and
1% penicillin–streptomycin solution, until 80% confluence
was attained. Experiments were subsequently initiated by
trypsinization of adherent cells and seeding cells in GM at a
density of 40 9 103 cells/mL for 12-well plates (1 mL total
volume) or 50 9 103 cells/mL for 6-well plate (2 mL total
volume). Plates had been prior coated with 0.2% gelatin for
5 minutes at room temperature with excess gelatin aspirated
prior to cell seeding. Upon attaining 90–100% confluency
GM was removed and cells were washed once with phos-
phate buffered saline (PBS). For the 0-h time point cells were
subsequently lysed at this stage. For later differentiation, time
points differentiation media (2% HS, 1% penicillin–strepto-
mycin solution, and 2 mmol/L L-glutamine) were added
(1 mL per well for 12-well plate, 2 mL per well for 6-well
plate) for indicated time points and subsequently were
removed with cells being washed one time with PBS prior to
lysis with the desired lysis buffer (see below).
Cell treatments and extractions
For both the BpV and nutrient challenge study, the 0-h
time point described above was the initiation time point.
Differentiation medium (DM) containing 10 lmol/L BpV
(Bpv dissolved in distilled H2O) or DM without BpV was
added to cells which were grown simultaneously in three
independent experiments. For RNA isolation experiments,
cells were grown in 12-well plates, and 150 lL of Tri Reagent
(Ambion, U.K.) was added to each well and left at room
temperature for 5 min with occasional agitation to enable
cell lysis. For sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE), cells were grown in 6-well plates
and 150 lL of SDS-PAGE lysis buffer (10 mmol/L Tris-Cl,
5 mmol/L ethylenediaminetetraacetic acid, 50 mmol/L NaCl,
30 mmol/L Na4P2O7, 50 mmol/L NaF, 100 lmol/L Na3VO4,
1 mmol/L phenylmethanesulfonyl fluoride, and 1% Triton
X-100 pH 8.3) was added per well. Cells were left on ice for
5 min to enable lysis with occasional agitation and subse-
quently cell scrapers were used to aid in complete lysate
removal. All samples were stored at 80°C until analysis.
Microscopy
For capture of phase contrast cell images, a cell imaging sys-
tem at 109 magnification (Leica, DMI 6000 B, Wetzlar,
Germany) was used.
Animal tissue RNA and protein isolation
All mouse tissue was obtained from c57/BL6 mice.
Whole-brain samples D16 (n = 6) were kindly provided
by Dr. Stuart Lanham Southampton University. For RNA
isolation, whole brains (n = 3) were pooled and homoge-
nized on ice in 1 mL of Tri reagent. For RNA isolation
from adult male Wistar rats (kind gift of Dr. May Azaw-
azi Manchester Metropolitan University), 20 mg of tissue
was obtained via 20-lm cryosections, placed in 1 mL of
Tri reagent and subsequently homogenized on ice.
Rt-pcr
Ribonucleic acid concentration was determined using a
Biotech Photometer (WPA UV1101, Biochrom, Cambridge,
U.K.). For two-step RT-PCR using custom-designed
primers, 2 lg of RNA was DNase treated and reverse
transcribed using the Quantitect reverse transcription kit
(Qiagen, U.K.) according to manufactures guidelines.
A 2-lL cDNA aliquot was subsequently used in 25-lL total
volume PCR which was conducted in accordance with
manufacturers (Taq Core Qiagen, Crawley, U.K.) guidelines
on an Eppendorf master cycler (Eppendorf, U.K.). Anneal-
ing temperatures of primers were 55°C and primer concen-
tration was 2.5 lmol/L. Primer sequences 5′-3′ used were as
follows: Kirrel A-specific primer set – forward primer
CGTGGAGAGGACGAACTCAG and reverse primer
GGCACGGTAGTCAGCATACA; and Kirrel B-specific
primer set – forward primer ATGAGAGTCGCTATGAG-
ACAACG, reverse primer – GCCGTAGGACAATGAAGA-
GC. PCR products were run on a 1% agarose gel alongside a
100 bp ladder (Invitrogen, U.K.) for size quantification and
visualized by ethidium bromide staining and UV detection
on a Bio-rad Gel DocTM XR supported by Quantity One 4.6.2
(Bio-rad).
For qPCR, RNA was DNase treated with DNA free
(Life Technologies) according to manufacturer’s guide-
lines, and subsequently, 160 ng of DNase-treated RNA
was used per qPCR reaction (20 lL total volume). Each
sample was run in duplicate on a 96-well plate (Bio-rad).
TaqMan RNA-to-CTTM one-step (Life Technologies) was
used for qPCR. Thermal cycler (Chromo4TM DNA engine
Biorad) conditions were used as recommended for
TaqMan RNA-to-CTTM one-step kit by manufacturer.
TaqMan probe used for Kirrel was Mm01209463. Gene
expression levels were calculated using the comparative
2DDCT method (Livak and Schmittgen 2001), where
RNA polymerase II DNA-directed polypeptide b (polr2b;
NM_153798) was used as reference gene (TaqMan probe
Mm00464214), as this gene has been previously validated
by our research group (Dimchev et al. 2013; Sharples
et al. 2010). For analysis of Kirrel gene expression during
C2C12 differentiation, consecutive hours were grouped
20, 21, and 22 h (20–22 h); 40, 41, and 42 h (40–42 h);
and 70 h, 71, and 72 h (70–72 h) to give an accurate
indication of Kirrel expression at specific stages of myo-
ª 2013 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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genesis, that is, Days 1, 2, and 3 and are expressed relative
to 0-h time point.
SDS-PAGE and immunodetection
Protein concentration of cell lysates was determined using
the bicinchoninic acid assay (Pierce, Thermo Fischer Sci-
entific, U.K.) and Bovine serum albumin (BSA) concen-
tration standards. Protein concentration was measured on
a Bio Tek Elisa Plate reader EL9800 (Bedfordshire, U.K.).
Forty lg of protein was loaded per lane for all samples
with 19 Lamelli buffer (50 mmol/L Tris-HCL, pH 6.8,
10% glycerol, 2% SDS, 1% mercaptoethanol, and 0.1%
bromophenol blue). Samples were heated at 100°C for
5 min and then spun (1 min 5000g). SDS-PAGE was per-
formed with a 7% resolving gel using a pharmacia biotech
power supply (EPS 3500) and Hoefer scientific gel casting
system (SE600). Semidry transfer (BDH Semi-Dry elec-
troblotter Merck Eurolab, Dorset, U.K.) was subsequently
conducted onto nitrocellulose membranes (Amersham GE
Healthcare, Buckinghamshire, U.K.). Equal protein load-
ing and transfer was confirmed via Ponceau S staining.
Membranes were subsequently washed to remove Ponceau
S and then blocked with 5% semiskimmed milk in 19
tris buffered saline with tween (TBST) (50 mmol/L Tris,
150 mmol/L NaCl, and 0.1% Tween 20). Membranes
were then incubated overnight at room temperature
(18–20°C) with primary polyclonal rabbit anti-human
Kirrel antibody (Abcam ab82804), 1:4000 dilution in 5%
semiskimmed milk in 19 TBST with gentle agitation, and
were subsequently washed 39 for 5 min and incubated
with horse raddish peroxidase-conjugated goat antirabbit
secondary antibody (Mp biomedical), 1:25,000 in 19
TBST with 5% semiskimmed milk for 1 h at room
18–20°C. Following secondary antibody incubation,
membranes were washed 49 for 5 min in 19 TBST.
Subsequently membranes were incubated with SuperSig-
nal West Femto–enhanced chemiluminescence (ECL)
reagents (Pierce, Thermo Fischer Scientific). Light inten-
sity was captured via Chemi DocTM XRS (Bio-rad) which
was supported by Quantity one 4.6.2 software (Bio-rad).
Postdetection of Kirrel, membranes were washed 29 with
19 TBST and reincubated for 4 h at 18–20°C with a
monoclonal rabbit antimouse b-Actin (New England
Biolabs -5125, Hertfordshire, U.K.) primary antibody,
1:5000 suspended in 19 TBST with 3% BSA. Detection
of b-Actin was as described for Kirrel. For analysis of
Kirrel protein expression during C2C12 differentiation,
consecutive hours were grouped 20, 21, and 22 h
(20–22 h); 40, 41, and 42 h (40–42 h); and 70, 71, and
72 h (70–72 h) to give an accurate indication of Kirrel
expression at specific stages of myogenesis, that is, Days
1, 2, and 3.
Statistics
Statistical analyses were carried out using SPSS version
18. One-way analysis of variance (ANOVAs) were carried
out when >2 comparisons were being made and Bonfer-
roni post hoc tests were subsequently carried out to
obtain statistical significance. When only two compari-
sons were being made, student’s t-test was used. Statistical
significance was set at P < 0.05. Values are expressed as
mean  standard error of mean (SEM).
Results
Identification of Kirrel B
Searching of the murine National Centre for Biotechnol-
ogy Information (NCBI) database (www.ncbi.nlm.nih.
gov) for Kirrel yielded two validated transcripts
NM_001170985.1 (hereafter known as Kirrel A) and
NM_130867.3, the former being three nucleotides longer
at 7287 bases. The small discrepancy maps to a splice site
at the 3′ end of the untranslated first exon; however, both
transcripts encode the same mature Kirrel protein. The
consensus coding sequence (CCDS) for murine Kirrel is
CCDS17450.1. The Basic Local Assignment Search Tool
(BLAST) available at http://blast.ncbi.nlm.nih.gov/blast.cgi
was utilized to search the NCBI murine nonredundant
nucleotide (nr/nt) database for possible previously unre-
ported splice variants of Kirrel using the CCDS17450.1
nucleotide sequence as template. This search yielded a
previously unreported mRNA sequence bc023765 (hereaf-
ter referred to as Kirrel B) which contained 2228 nucleo-
tides. The Kirrel B mRNA transcript, which contains a
poly A tail, was identified in a murine mammary tumor.
Aligning the transcript sequences of Kirrel A and Kirrel B
to the mouse genome via the genomic sequence present
in NT_039240.7, it was found that Kirrel A and B contain
16 and 14 exons, respectively (see Fig. 1 for schematic).
Kirrel A has an additional two unique exons (of 79 and
5030 nucleotides) at its 3′ end and an additional 197
nucleotides at its 5′ end which are not present in Kirrel
B. Kirrel A and Kirrel B are predicted via the open-read-
ing frame finder software (available at www.ncbi.nlm.nih.
gov/projects/gorf/) to share the same ATG translation
start codon in their second exons at nucleotide 366 and
179, respectively. Between nucleotides 11 and 1993 of
Kirrel B, which spans exons 1–14 of both transcripts,
identical sequence data are present in Kirrel A. The first
10 nucleotides of Kirrel B do not map to the murine gen-
ome and the reason for this is currently unknown. A
missed spliced site that is present in exon 14 of Kirrel A
at position 2180 results in the production of a truncated
Kirrel B transcript with a thymine, Adenine, Adenine
2013 | Vol. 1 | Iss. 3 | e00044
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(TAA) stop codon present 87 nucleotides 3′ to the missed
spliced site. Following the TAA stop codon, a 3′ untrans-
lated region of ~85 nucleotides is present prior to the
poly A tail. Comparing the protein-coding sequence of
CCDS 17450.1 with the Kirrel A transcript sequence it
was observed that Kirrel A contains a significantly larger
3′ untranslated region of approximately 4550 nucleotides.
In silico analysis of protein structures for
Kirrel A and B
The predicted molecular weights of unmodified Kirrel A
(NP_001164456.1) and Kirrel B (AAH23765) isoforms are
~87 kDa and 70 kDa, respectively. Kirrel A contains 789
amino acids (aa), whereas Kirrel B is shorter at 634 aa.
The first 605 aa of both isoforms are identical. This
homologous coding sequence (see Fig. 2 for schematic)
encodes a region spanning from the signal peptide to the
53rd cytoplasmic amino acid. Domains present in this
homologous sequence include a signal peptide aa 1–47
(www.cbs.dtu.dk/services/signalip/); five extracellular
immunoglobulin domains (Ig): aa 54–151, 151–243, 256–
339, 340–422, and 424–509 (http://scansite.mit.edu); and
a transmembrane domain between aa 529 and 551 (www.
cbs.dtu.dk/services/tmhmm/). The cytoplasmic domain of
Kirrel A subsequently differs to that of Kirrel B as it con-
tains two tyrosine (Y) residues (Y637 and Y638) which
regulate growth factor receptor bound 2 (Grb2) binding
in in vitro assays and also in Kirrel A pull down assays
for Grb2 from rodent kidney lysates (Garg et al. 2007;
Harita et al. 2008). A post synaptic density protein
95, Drosophila disc large tumour suppressor, zonula
occludens 1 (PDZ) binding domain motif is also present
at the c-terminus of Kirrel A aa 787–789 (Sellin et al.
2003). While the truncated cytoplasmic domain present
in Kirrel B leads to the loss of the Grb2 and PDZ motifs,
a putative phosphatidylinositol-3,4,5-triphosphate pleck-
strin homology (PIP3 PH) motif is predicted between aa
607 and 621(http://scansite.mit.edu). This domain is not
predicted to be present in Kirrel A.
Expression profiling of Kirrel A and B mRNA
transcripts
To examine for the presence of both Kirrel A and B
mRNA transcripts in C2C12 cells, a two-step RT-PCR
strategy with transcript-specific primer sets was employed.
Multiple time points were assessed during C2C12 differ-
entiation, whereby C2C12 cells move from a mononucle-
ated state to form multinucleated myotube like structures
via somatic cell fusion events (Fig. 3A). Additional mouse
and rat muscle tissues were also analyzed. The Kirrel A
primer set had an expected amplicon of 555 nucleotides,
whereas the Kirrel B primer set had an expected amplicon
of 968 nucleotides. As a positive control for the Kirrel A
primer set, murine brain and rat kidney tissues were
included as Kirrel A has been previously reported to be
present in these tissues (Gerke et al. 2006; Liu et al.
2003). Amplicons of the expected size were obtained for
Kirrel A in all C2C12 differentiation time-course samples
0, 22, 42, and 72 h (Lanes 2–5 Fig. 3B) and in all mouse
and rat tissues analyzed (Lanes 6–10 Fig. 3B), thus
providing evidence that the Kirrel A transcript is present
in C2C12 cells and also in adult rat skeletal muscle (Lane
Figure 1. Schematic illustrating exon structure and transcript differences between Kirrel A and Kirrel B. ATG codon prediction obtained from
open-read frame finder software available at (www.ncbi.nlm.nih.gov/projects/gorf).
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Figure 2. Schematic of a selection of structural domains present in Kirrel A and Kirrel B. Signal peptide, immunoglobulin domains, and
transmembrane domain prediction obtained from UniProt (www.uniprot.org). Cytoplasmic structural domains obtained from preforming a high
stringency scan via Scansite (http://scansite.mit.edu). Y638 was not predicted by Scansite, however, this site has previously been reported to be
essential for Grb2 binding (Harita et al. 2008). PDZ domain in Kirrel was previously reported (Sellin et al. 2003).
Figure 3. Expression of Kirrel mRNA transcripts during C2c12 differentiation and in additional rodent tissues. (A) Phase contrast images of
C2C12 cells grown in DM for the indicated time durations. (B) PCR amplicons obtained from PCR using Kirrel A-specific primer set to detect
Kirrel A. Lane 1 – 100 bp DNA ladder; Lanes 2–5 – C2C12 differentiation time course 0, 22, 42, and 72 h; Lane 6 – rat skeletal muscle; Lane 7
– mouse eye; Lane 8 – mouse brain; Lane 9 – mouse heart; Lane 10 – mouse kidney; Lane 11 – empty; and Lane 12 – negative control. (C)
Amplicons obtained from PCR using Kirrel B-specific primer set to detect Kirrel B. (C) Lane 1 – 100 bp Ladder; Lanes 2–11 – C2C12
differentiation time-course samples 0, 20, 21, 22, 40, 41, 42, 70, 71, and 72 h; Lane 12 – mouse brain; Lane 13 – empty; and Lane
14 – negative control. (D) qPCR results for total Kirrel mRNA expression levels (i.e., Kirrel A and B combined) during C2C12 differentiation.
20–22 h (20, 21, and 22 h), 40–42 h (40, 41, and 42 h), 70–72 h (70, 71, and 72 h). Results are representative of n = 3 separate experiments.
Represents statistical significance obtained at P < 0.05.
2013 | Vol. 1 | Iss. 3 | e00044
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6 Fig. 3B). Additional primer sets were used to confirm
the presence of Kirrel A (data not shown). Amplicons of
the expected size were also obtained for Kirrel B in all
differentiation time-course samples from C2C12 cells
(Lanes 2–11 Fig. 3C) and mouse brain (Lane 12
Figure 3C). Presence of a Kirrel B transcript in C2C12
cells was confirmed with two additional primer sets (data
not shown). It was subsequently of interest to obtain
quantitative mRNA expression data on Kirrel during
C2C12 differentiation. Attempts were made to obtain
quantitative expression data on the individual Kirrel
splice variants; however, difficulties were encountered in
obtaining consistent reliable expression data on Kirrel B
as it appears to be expressed at a much lower level than
Kirrel A. A focus was therefore put on analysis of total
Kirrel mRNA levels via the use of a Taq Man probe
which could detect both Kirrel A and Kirrel B mRNA
transcripts. A gradual reduction in total Kirrel mRNA
expression levels as differentiation progressed between
Days 1 and 3 was observed (Fig. 3D). Statistically signifi-
cant changes (mean + SEM) of ~1.5- to 2-fold in relative
Kirrel mRNA expression levels were found between 20
and 22 h versus 40 and 42 h (1.2 + 0.05 vs. 0.92 + 0.07;
P < 0.05), 20 and 22 h versus 70 and 72 h (1.2  0.05
vs. 0.66  0.03; P < 0.05), and 40 and 42 h versus 70
and 72 h (0.92  0.07 vs. 0.66  0.03; P < 0.05).
Expression profiling of Kirrel A and B
protein Isoforms
To assess for the possible protein presence of both Kirrel
A and B in C2C12 cells during in vitro myogenesis, a
commercial antibody was utilized. The predicted molecu-
lar weights of Kirrel A and B were 87.19 kDa and
69.98 kDa, respectively (www.bioinformatics.org/sms/
prot_mw.html). Murine brain tissue was also included for
analysis as Kirrel has previously been reported to be
expressed in this tissue (Gerke et al. 2006) and our RT-
PCR studies had suggested that Kirrel B was also present
in the mouse brain. Multiple immunoreactive proteins
between ~90 and 125 kDa were detected in C2C12 cells
(Fig. 4A Lanes 1–10) with the most intense signal present
at ~125 kDa, which is in close size agreement with previ-
ous reports of Kirrel detection in the mouse kidney
(Liu et al. 2003). Additional strong and consistent immu-
noreactive proteins were also detected at ~70 kDa which
closely matches the predicted size of Kirrel B. Immunore-
active proteins at ~125 and 70 kDa were also detected in
murine brain (Fig. 4B) and hence were in agreement with
our RT-PCR data. Prior incubation of the anti-Kirrel
antibody with a blocking peptide resulted in either the
total or almost complete elimination of immunoreactive
proteins in C2C12 cells and mouse brain (data not
Figure 4. SDS-PAGE and immunodetection of Kirrel. (A) Lanes 1–10 – C2C12 differentiation time course 0, 20, 21, 22, 40, 41, 42, 70, 71,
and 72 h. Results are representative of n = 3 separate experiments. (B) Mouse brain. (C) Relative protein expression levels of Kirrel A (i.e.,
~125 kDa immunoreactive band) during C2C12 differentiation time course. (D) Relative Kirrel B (i.e., ~70 kDa band) protein expression during
C2C12 differentiation time course. Results obtained from n = 3 separate experiments. Represents statistical significance obtained at
P < 0.05.
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shown), thus suggesting that these are Kirrel immunore-
active proteins. Quantitative analysis of the expression
pattern of Kirrel A (125 kDa) and B (70 kDa – smallest
of the two proteins) during C2C12 differentiation found
no significant difference occurring in expression of Kirrel
A (Fig. 4C). Statistically significant increased expression
of approximately threefold and twofold was observed in
Kirrel B protein levels at 20–22 h compared to 40–42 and
70–72 h, respectively (1.84  0.32 vs. 0.51  0.14 AU,
P < 0.05; and 1.84  0.32 vs. 0.74  0.24 AU, P < 0.05)
(Fig. 4D).
Characterization of Kirrel mRNA and protein
expression in response to chemical
inhibition of the cell fusion process
To continue our investigation of Kirrel expression during
in vitro myogenesis and to investigate a possible correla-
tion with cell fusion, we utilized the BpV chemical com-
pound which is a phosphotyrosine phosphatase inhibitor
and has previously been demonstrated to significantly alter
the cell fusion process in C2C12 cells (Castaldi et al.
2007), and is confirmed in our studies also (Fig. 5A). The
impairment of the cell fusion process is associated with
significant decreases in expression of the muscle-specific
transcription factor myogenin. The expression of myoge-
nin mRNA in BpV-treated cells compared to control cells
(Fig. 5B) is significantly decreased by approximately five-
fold (0.28  0.07 vs. 1.68  0.13; P < 0.01) after 42 h
and approximately twofold (0.68  0.16 vs. 1.16  0.11;
P < 0.05) 72 h postaddition of DM. At the 22-h time
point, a clear trend toward lower expression in the BpV-
treated samples compared to control was also observed
(0.24  0.05 vs. 1.1  0.28; P = 0.06). In comparison to
myogenin mRNA levels, no statistically significant differ-
ence was observed in total Kirrel mRNA levels (Fig. 5C) at
22 h or 42 h between control and BpV-treated cells; how-
ever, a significant increase in Kirrel mRNA of approxi-
mately twofold was observed in BpV-treated cells
compared to control at 72 h (1.73  0.11 vs. 0.89  0.06;
P < 0.05).
No statistically significant difference was observed in
Kirrel A protein levels between BpV treated and control
at any of the time points analyzed (Fig. 6A). In compari-
son at 22 and 42 h, Kirrel B expression levels were
approximately threefold higher in BpV-treated cells com-
pared to control (3.10  0.72 and 3.43  0.79, P < 0.05;
Fig. 6B), whereas at 72 h, Kirrel B expression levels were
approximately twofold (2.09  0.38; P < 0.05 Fig. 6B)
higher in BpV-treated cells compared to control.
Figure 5. (A) Phase contrast images of C2C12 cells which had been treated with 10 lmol/L BpV. For comparison of difference in fusion
inhibition to non-BpV–treated cells compare with Figure 2A. (B) Relative myogenin mRNA expression levels in control C2C12 cells and those
treated with 10 lmol/L BpV during differentiation time course. (C) Relative Kirrel mRNA expression levels in control C2C12 cells and those
treated with 10 lmol/L BpV during differentiation time course. Represents statistical significance obtained at P < 0.05. Results are
representative of n = 3 separate experiments.
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Discussion
Our understanding of the somatic cell fusion process in
mammals which is a critical component for skeletal mus-
cle development is currently at a rudimentary stage.
Somatic cell fusion is recognized as being essential for
numerous developmental and postnatal physiological pro-
cesses including trophoblast development (Dupressoir
et al. 2009), skeletal muscle growth (Horsley and Pavlath
2004), and osteoclast function (Ishii and Saeki 2008). Fur-
thermore, evidence is also beginning to emerge that the
occurrence of somatic cell fusion may be more wide-
spread than previously recognized, as evidence of somatic
cell fusion events have also been reported in brain (Alv-
arez-Dolado et al. 2003; Johansson et al. 2008), intestinal
epithelium (Davies et al. 2009), liver (Faggioli et al.
2008), prostate (Placencio et al. 2010), and also cancer
cells (Carter 2008; Duelli and Lazebnik 2003). Such find-
ings are suggestive that improved mechanistic under-
standing of the somatic cell fusion process may elucidate
novel therapeutic tools. Utilizing somatic cell fusion as a
therapeutic aid has been attempted for treatment of mus-
cular dystrophy in humans (Mendell et al. 1995; Miller
et al. 1997). However, to date it has been unsuccessful in
generating clinically beneficial results thus further sup-
porting the need for increased knowledge of the molecu-
lar underpinnings of the somatic cell fusion process.
In light of such findings we investigated the Kirrel
gene, a mammalian homolog of the Drosophila genes Rst
and Kirre (Neumann-Haefelin et al. 2010), which have
been shown to be key regulators of muscle cell fusion
events during embryonic development in Drosophila
(Str€unkelnberg et al. 2001). Currently, rudimentary
knowledge is available regarding Kirrel in mammalian
skeletal muscle. Our results highlight the presence of two
Kirrel transcripts in murine skeletal muscle cells and in
the murine brain which is a previously unreported find-
ing. The resultant proteins predicted to be encoded by
these transcripts we term Kirrel A and Kirrel B. Signifi-
cant structural differences are predicted to exist in the
cytoplasmic domains of Kirrel A and B, which likely con-
fer differential signaling capabilities to either isoform. Of
particular note with regards to cell fusion is the loss of
the GRB2-binding motif from Kirrel B. The GRB2-bind-
ing motif present in Kirrel A has been demonstrated to
enable Kirrel A to induce actin nucleation at the plasma
membrane of mammalian cells (Garg et al. 2007). Actin
nucleation at the plasma membrane is essential for the
muscle cell process in Drosophila and also in mammals
(Abmayr and Pavlath 2012; Sens et al. 2010). Expression
profiling of Kirrel B protein levels during in vitro myo-
genesis found its expression to be highest 1 day postaddi-
tion of DM, lowest 2 days postaddition of DM, and
intermediate expression levels 3 days postaddition of DM.
This expression pattern inversely matches the rate of
occurrence of cell fusion events of C2C12 cells which is
lowest 1 day postaddition of DM and highest 2 days
postaddition of DM (Velica and Bunce 2011). Chemical
inhibition of the cell fusion process via treatment with
BpV leads to significant increases in Kirrel B protein
Figure 6. (A) Relative fold change of Kirrel A (~125 kDa) protein expression levels in control and 10 lmol/L BpV-treated C2C12 cells at
indicated time points during C2C12 differentiation time course. (B) Relative fold change in Kirrel B (~70 kDa) protein expression levels in control
and 10 lmol/L BpV-treated C2C12 cells at indicated time points during C2C12 differentiation time course. (C) B-Actin loading control.
Represents statistical significance obtained at P < 0.05. Results are representative of n = 3 separate experiments.
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levels compared with controls; thus, mirroring the results
obtained under standard differentiation culture conditions
and further linking Kirrel B protein expression levels
inversely with the occurrence of cell fusion events in skel-
etal muscle cells. Surprisingly we observed that Kirrel A
protein expression levels, as assayed via the presence of a
likely heavily posttranslationally modified immunoreactive
band migrating at ~125 kDa, did not display any signifi-
cant perturbations in expression levels such as those
described for Kirrel B. Our findings with regards to Kirrel
A protein levels were similar to those observed for total
Kirrel mRNA expression levels, which displayed small
alterations during in vitro myogenesis and in response to
our experimental interventions.
The structural analysis of Kirrel A and B highlights that
both isoforms share an identical extracellular domain,
therefore, Kirrel A and B may compete for interaction
with the same extracellular ligand. The recent finding
with regards to the importance of the murine homolog of
SnS, Nephrin in murine skeletal muscle cell fusion, and
the expression pattern of Nephrin being positively corre-
lated with muscle cell fusion events (Sohn et al. 2009)
makes it tempting to hypothesize that the decreased
expression of Kirrel B when fusion rates are high may
enable increased interactions between Kirrel A and Neph-
rin as protein expression levels of Kirrel A remain rela-
tively constant throughout the differentiation time course
of C2C12 cells. Such a scenario of Kirrel A and Nephrin
interaction would mirror research findings from Drosoph-
ila Schneider cells demonstrating that Kirre and SnS can
interact in trans (Galletta et al. 2004) and that they colo-
calize in trans in vivo at sites undergoing muscle cell
fusion during embryonic development in Sens et al.
(2010). Intriguingly in mouse L fibroblasts Kirrel A has
been reported to interact in trans with Nephrin (Heikkil€a
et al. 2011), thus providing support for the possibility
that a similar interaction may occur in mammalian mus-
cle cells.
Notably in Drosophila at sites of fusion where SnS and
Kirre colocalize in trans, significant actin nucleation
occurs (Sens et al. 2010), likely due to the recruitment of
pronucleation factors by Kirre and SnS (Abmayr and
Pavlath 2012; Richardson et al. 2008). If components of
the actin nucleation pathway such as the Wiskott Aldrich
protein (WASP) are absent from muscle cells, the fusion
process is blocked at the cell–cell adhesion stage between
Kirre and SnS (Sens et al. 2010), thus highlighting the
importance of localized actin nucleation at the cell mem-
brane to the cell fusion process. Considering that Kirrel B
lacks the GRB2-binding domains which enable Kirrel A
to induce localized actin nucleation at the plasma mem-
brane of mammalian cells (Garg et al. 2007), it could be
hypothesized that Kirrel B may negatively regulate the cell
fusion process by sequestering potential trans interactions
of Kirrel A with other profusion partners such as Neph-
rin. Actin nucleation may therefore be prevented from
occurring in the cell which expresses Kirrel B, thus, inhib-
iting cell fusion events. In Drosophila, it has been shown
that actin nucleation occurs in both the cells which are
undergoing fusion (Sens et al. 2010).
It is noteworthy that Kirrel B protein expression levels
are inverse to the expression levels of myogenin, which is
a key transcription factor for skeletal muscle differentia-
tion (Rawls et al. 1995), a process which is characterized
by the formation of multinucleated muscle fibers in vivo.
Interestingly it has been demonstrated that as C2C12 cells
differentiate and begin to form multinucleated myotubes,
changes occur in the alternative splicing of mRNA tran-
scripts (Bland et al. 2010). Therefore, the alternative splic-
ing of Kirrel to yield both A and B protein isoforms may
be indirectly regulated by myogenin via the ability of my-
ogenin to drive the differentiation program of skeletal
muscle cells and, hence, alter splicing events of mRNA
transcripts such as Kirrel in skeletal muscle cells.
Decreased production of the Kirrel B mRNA transcript
due to changes in the spliceosome as a result of the dif-
ferentiation process may as hypothesized above favor cell
fusion events via enabling Kirrel A and Nephrin interac-
tion. Overexpression studies of the Kirrel B isoform
should provide an answer as to whether Kirrel B may be
capable of inhibiting the somatic cell fusion process of
skeletal muscle.
In the mammalian genome there are two additional
Kirrel family members Kirrel2 and Kirrel3 (Neumann-
Haefelin et al. 2010). Currently it remains unclear
whether Kirrel3 is present or absent in mammalian skele-
tal muscle. A Kirrel3 mRNA transcript was not detected
in an analysis of murine skeletal muscle (Ueno et al.
2003). However, contrary to this, it has been reported
that sera raised against Kirrel3 detected a strong immuno-
reactive band in murine skeletal muscle at approximately
100 kDa which the authors suggest to possibly be a post-
translationally modified form of Kirrel3 (Gerke et al.
2005). Furthermore, it has been reported that in embry-
onic murine skeletal muscle (E17.5), Kirrel3 and Nephrin
coimmunoprecipitate (Morikawa et al. 2007). This inter-
action was suggested as occurring at muscle spindle sites
due to results from in situ hybridization studies, which
found Kirrel3 to be present in proprioceptive neurons of
the dorsal root ganglia while Nephrin was reported to be
present in Neurotrophin 3–positive intrafusal muscle
fibers. It will therefore be of interest to examine in detail
the entire Kirrel family and possible interactions with
Nephrin to ascertain their possible multiple diverse func-
tions during myogenesis. Due to the highly similar
extracellular domain present among mammalian Kirrel,
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Kirrel2, and Kirrel3 and their shared capability of inter-
acting with similar proteins such as Podocin (Sellin et al.
2003), the possibility of redundancy among this family of
genes is suggested. Such potential redundancy will need
to be considered when attempting to elucidate how these
genes may be involved in developmental processes, such
as somatic cell fusion, where the absence of one family
member, generated using knock-out technology, may be
compensated for by another and hence no overt develop-
mental or physiological defects may be displayed.
The presence of Kirrel B in murine brain tissue also
requires further examination as the C. elegans homolog of
Kirrel, SYG-1, is known to be involved in synaptogenesis
(Wanner et al. 2011). Kirrel has been reported to be pres-
ent at synapses in the murine brain (Gerke et al. 2006),
however, the antibody used was directed toward the
extracellular domain of Kirrel and so would not have
been able to distinguish between Kirrel A and B. With
the development of isoform-specific antibodies it will be
of interest to examine the spatial distribution of both Kir-
rel isoforms in murine tissues. Finally, 3′ and 5′ race
experiments will be required to examine whether both
Kirrel isoforms originate from the same genomic locus
and whether the untranslated regions of the transcripts
vary between cell types. Such information will help eluci-
date possible regulatory mechanisms such as micro-RNAs
(miRNAs) controlling expression of the alternatively
spliced Kirrel transcripts in different cell types.
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